HEADER MEMBRANE PROTEIN 14-JUL-10 3NY9 TITLE CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENERGIC RECEPTOR IN COMPLEX TITLE 2 WITH A NOVEL INVERSE AGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-2 ADRENERGIC RECEPTOR, LYSOZYME; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CHIMERIC PROTEIN OF BETA-2 ADRENORECEPTOR 1-230, LYSOZYME COMPND 5 2-161, BETA-2 ADRENERGIC RECEPTOR 263-348; COMPND 6 SYNONYM: BETA-2 ADRENORECEPTOR, BETA-2 ADRENOCEPTOR, LYSIS PROTEIN, COMPND 7 MURAMIDASE, ENDOLYSIN; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ENTEROBACTERIA PHAGE T4; SOURCE 3 ORGANISM_TAXID: 9606, 10665; SOURCE 4 GENE: ADRB2, ADRB2R, B2AR, E; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFASTBAC KEYWDS G PROTEIN-COUPLED RECEPTOR, LYSOZYME, FUSION, TRANSDUCER, ADRENERGIC, KEYWDS 2 G-PROTEINS, ARRESTINS, ADRENALIN, COMPOUND 2, GLYCOSYLATION, KEYWDS 3 PALMITOYLATION, PHOSPHORYLATION, MEMBRANE PROTEIN, HYDROLASE, KEYWDS 4 STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, KEYWDS 5 ACCELERATED TECHNOLOGIES CENTER FOR GENE TO 3D STRUCTURE, ATCG3D, KEYWDS 6 GPCR NETWORK, GPCR EXPDTA X-RAY DIFFRACTION AUTHOR G.FENALTI,D.WACKER,M.A.BROWN,V.KATRITCH,R.ABAGYAN,V.CHEREZOV, AUTHOR 2 R.C.STEVENS,ACCELERATED TECHNOLOGIES CENTER FOR GENE TO 3D STRUCTURE AUTHOR 3 (ATCG3D),GPCR NETWORK (GPCR) REVDAT 8 06-NOV-24 3NY9 1 REMARK REVDAT 7 06-SEP-23 3NY9 1 REMARK SEQADV REVDAT 6 02-AUG-17 3NY9 1 SOURCE REMARK REVDAT 5 08-AUG-12 3NY9 1 REMARK REVDAT 4 23-MAY-12 3NY9 1 DBREF SEQADV VERSN REVDAT 3 01-SEP-10 3NY9 1 JRNL REVDAT 2 25-AUG-10 3NY9 1 JRNL REVDAT 1 11-AUG-10 3NY9 0 JRNL AUTH D.WACKER,G.FENALTI,M.A.BROWN,V.KATRITCH,R.ABAGYAN, JRNL AUTH 2 V.CHEREZOV,R.C.STEVENS JRNL TITL CONSERVED BINDING MODE OF HUMAN BETA(2) ADRENERGIC RECEPTOR JRNL TITL 2 INVERSE AGONISTS AND ANTAGONIST REVEALED BY X-RAY JRNL TITL 3 CRYSTALLOGRAPHY JRNL REF J.AM.CHEM.SOC. V. 132 11443 2010 JRNL REFN ISSN 0002-7863 JRNL PMID 20669948 JRNL DOI 10.1021/JA105108Q REMARK 2 REMARK 2 RESOLUTION. 2.84 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.84 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.77 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 11620 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.222 REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 612 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.84 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.91 REMARK 3 REFLECTION IN BIN (WORKING SET) : 730 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.3120 REMARK 3 BIN FREE R VALUE SET COUNT : 38 REMARK 3 BIN FREE R VALUE : 0.3820 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3466 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 105 REMARK 3 SOLVENT ATOMS : 8 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 58.38 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.70000 REMARK 3 B22 (A**2) : -0.74000 REMARK 3 B33 (A**2) : -4.96000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.446 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.372 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 19.156 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.889 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3660 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4986 ; 1.230 ; 1.971 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 438 ; 4.878 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 146 ;38.843 ;23.082 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 585 ;16.677 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;20.653 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 589 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2647 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3NY9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-JUL-10. REMARK 100 THE DEPOSITION ID IS D_1000060429. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-NOV-09; 10-DEC-09 REMARK 200 TEMPERATURE (KELVIN) : 100; 100 REMARK 200 PH : 7.5-8.0 REMARK 200 NUMBER OF CRYSTALS USED : 10 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : APS; APS REMARK 200 BEAMLINE : 23-ID-D; 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0332; 1.0332 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL; DOUBLE CRYSTAL REMARK 200 OPTICS : NULL; NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD; CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD; MARMOSAIC REMARK 200 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12234 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.840 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.4 REMARK 200 DATA REDUNDANCY : 3.840 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.13100 REMARK 200 FOR THE DATA SET : 7.0800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.84 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.98 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.93 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.43000 REMARK 200 FOR SHELL : 1.990 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3D4S REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS/HCL PH 7.5-8, 5% 1,4 REMARK 280 BUTANEDIOL, 220 MM NA-FORMATE, 27% PEG 400, LIPIDIC CUBIC PHASE REMARK 280 (LCP) CRYSTALLIZATION, TEMPERATURE 293-295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.29000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 87.09000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.95000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 87.09000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.29000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.95000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A -7 REMARK 465 TYR A -6 REMARK 465 LYS A -5 REMARK 465 ASP A -4 REMARK 465 ASP A -3 REMARK 465 ASP A -2 REMARK 465 ASP A -1 REMARK 465 ALA A 0 REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 GLN A 3 REMARK 465 PRO A 4 REMARK 465 GLY A 5 REMARK 465 ASN A 6 REMARK 465 GLY A 7 REMARK 465 SER A 8 REMARK 465 ALA A 9 REMARK 465 PHE A 10 REMARK 465 LEU A 11 REMARK 465 LEU A 12 REMARK 465 ALA A 13 REMARK 465 PRO A 14 REMARK 465 ASN A 15 REMARK 465 ARG A 16 REMARK 465 SER A 17 REMARK 465 HIS A 18 REMARK 465 ALA A 19 REMARK 465 PRO A 20 REMARK 465 ASP A 21 REMARK 465 HIS A 22 REMARK 465 ASP A 23 REMARK 465 VAL A 24 REMARK 465 THR A 25 REMARK 465 GLN A 26 REMARK 465 GLN A 27 REMARK 465 ARG A 28 REMARK 465 ASP A 29 REMARK 465 GLU A 30 REMARK 465 VAL A 31 REMARK 465 ARG A 343 REMARK 465 ARG A 344 REMARK 465 SER A 345 REMARK 465 SER A 346 REMARK 465 LEU A 347 REMARK 465 LYS A 348 REMARK 465 HIS A 349 REMARK 465 HIS A 350 REMARK 465 HIS A 351 REMARK 465 HIS A 352 REMARK 465 HIS A 353 REMARK 465 HIS A 354 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TRP A 32 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 32 CZ3 CH2 REMARK 470 LYS A 60 CG CD CE NZ REMARK 470 MET A 98 SD CE REMARK 470 THR A 100 OG1 CG2 REMARK 470 GLU A 107 CG CD OE1 OE2 REMARK 470 LYS A 147 CG CD CE NZ REMARK 470 ARG A 221 CG CD NE CZ NH1 NH2 REMARK 470 LYS A1016 CG CD CE NZ REMARK 470 LYS A1048 CG CD CE NZ REMARK 470 LYS A1083 CE NZ REMARK 470 GLN A1141 CG CD OE1 NE2 REMARK 470 LYS A1147 CG CD CE NZ REMARK 470 GLN A 299 CG CD OE1 NE2 REMARK 470 ARG A 304 NE CZ NH1 NH2 REMARK 470 GLU A 306 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 86 -58.94 -122.86 REMARK 500 TYR A 141 -7.65 85.60 REMARK 500 CYS A 191 49.00 -142.89 REMARK 500 ASP A1010 57.51 -101.58 REMARK 500 GLU A1011 -28.43 -168.13 REMARK 500 ILE A1029 79.84 -101.71 REMARK 500 PRO A1037 34.30 -94.08 REMARK 500 ILE A 298 -78.21 -67.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CLR A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CLR A 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JSZ A 1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OLC A 1204 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3D4S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENERGIC RECEPTOR IN COMPLEX REMARK 900 WITH THE INVERSE AGONIST TIMOLOL REMARK 900 RELATED ID: 2RH1 RELATED DB: PDB REMARK 900 HIGH-RESOLUTION CRYSTAL STRUCTURE OF AN ENGINEERED HUMAN BETA2- REMARK 900 ADRENERGIC G PROTEIN-COUPLED RECEPTOR REMARK 900 RELATED ID: 3NY8 RELATED DB: PDB REMARK 900 RELATED ID: 3NYA RELATED DB: PDB REMARK 900 RELATED ID: ATCG3D_18 RELATED DB: TARGETDB REMARK 900 RELATED ID: GPCR-15 RELATED DB: TARGETTRACK DBREF 3NY9 A 1 230 UNP P07550 ADRB2_HUMAN 1 230 DBREF 3NY9 A 1002 1161 UNP P00720 LYS_BPT4 2 161 DBREF 3NY9 A 263 348 UNP P07550 ADRB2_HUMAN 263 348 SEQADV 3NY9 ASP A -7 UNP P07550 EXPRESSION TAG SEQADV 3NY9 TYR A -6 UNP P07550 EXPRESSION TAG SEQADV 3NY9 LYS A -5 UNP P07550 EXPRESSION TAG SEQADV 3NY9 ASP A -4 UNP P07550 EXPRESSION TAG SEQADV 3NY9 ASP A -3 UNP P07550 EXPRESSION TAG SEQADV 3NY9 ASP A -2 UNP P07550 EXPRESSION TAG SEQADV 3NY9 ASP A -1 UNP P07550 EXPRESSION TAG SEQADV 3NY9 ALA A 0 UNP P07550 EXPRESSION TAG SEQADV 3NY9 ARG A 16 UNP P07550 GLY 16 VARIANT SEQADV 3NY9 GLN A 27 UNP P07550 GLU 27 VARIANT SEQADV 3NY9 TRP A 122 UNP P07550 GLU 122 ENGINEERED MUTATION SEQADV 3NY9 GLU A 187 UNP P07550 ASN 187 ENGINEERED MUTATION SEQADV 3NY9 THR A 1054 UNP P00720 CYS 54 ENGINEERED MUTATION SEQADV 3NY9 ALA A 1097 UNP P00720 CYS 97 ENGINEERED MUTATION SEQADV 3NY9 HIS A 349 UNP P07550 EXPRESSION TAG SEQADV 3NY9 HIS A 350 UNP P07550 EXPRESSION TAG SEQADV 3NY9 HIS A 351 UNP P07550 EXPRESSION TAG SEQADV 3NY9 HIS A 352 UNP P07550 EXPRESSION TAG SEQADV 3NY9 HIS A 353 UNP P07550 EXPRESSION TAG SEQADV 3NY9 HIS A 354 UNP P07550 EXPRESSION TAG SEQRES 1 A 490 ASP TYR LYS ASP ASP ASP ASP ALA MET GLY GLN PRO GLY SEQRES 2 A 490 ASN GLY SER ALA PHE LEU LEU ALA PRO ASN ARG SER HIS SEQRES 3 A 490 ALA PRO ASP HIS ASP VAL THR GLN GLN ARG ASP GLU VAL SEQRES 4 A 490 TRP VAL VAL GLY MET GLY ILE VAL MET SER LEU ILE VAL SEQRES 5 A 490 LEU ALA ILE VAL PHE GLY ASN VAL LEU VAL ILE THR ALA SEQRES 6 A 490 ILE ALA LYS PHE GLU ARG LEU GLN THR VAL THR ASN TYR SEQRES 7 A 490 PHE ILE THR SER LEU ALA CYS ALA ASP LEU VAL MET GLY SEQRES 8 A 490 LEU ALA VAL VAL PRO PHE GLY ALA ALA HIS ILE LEU MET SEQRES 9 A 490 LYS MET TRP THR PHE GLY ASN PHE TRP CYS GLU PHE TRP SEQRES 10 A 490 THR SER ILE ASP VAL LEU CYS VAL THR ALA SER ILE TRP SEQRES 11 A 490 THR LEU CYS VAL ILE ALA VAL ASP ARG TYR PHE ALA ILE SEQRES 12 A 490 THR SER PRO PHE LYS TYR GLN SER LEU LEU THR LYS ASN SEQRES 13 A 490 LYS ALA ARG VAL ILE ILE LEU MET VAL TRP ILE VAL SER SEQRES 14 A 490 GLY LEU THR SER PHE LEU PRO ILE GLN MET HIS TRP TYR SEQRES 15 A 490 ARG ALA THR HIS GLN GLU ALA ILE ASN CYS TYR ALA GLU SEQRES 16 A 490 GLU THR CYS CYS ASP PHE PHE THR ASN GLN ALA TYR ALA SEQRES 17 A 490 ILE ALA SER SER ILE VAL SER PHE TYR VAL PRO LEU VAL SEQRES 18 A 490 ILE MET VAL PHE VAL TYR SER ARG VAL PHE GLN GLU ALA SEQRES 19 A 490 LYS ARG GLN LEU ASN ILE PHE GLU MET LEU ARG ILE ASP SEQRES 20 A 490 GLU GLY LEU ARG LEU LYS ILE TYR LYS ASP THR GLU GLY SEQRES 21 A 490 TYR TYR THR ILE GLY ILE GLY HIS LEU LEU THR LYS SER SEQRES 22 A 490 PRO SER LEU ASN ALA ALA LYS SER GLU LEU ASP LYS ALA SEQRES 23 A 490 ILE GLY ARG ASN THR ASN GLY VAL ILE THR LYS ASP GLU SEQRES 24 A 490 ALA GLU LYS LEU PHE ASN GLN ASP VAL ASP ALA ALA VAL SEQRES 25 A 490 ARG GLY ILE LEU ARG ASN ALA LYS LEU LYS PRO VAL TYR SEQRES 26 A 490 ASP SER LEU ASP ALA VAL ARG ARG ALA ALA LEU ILE ASN SEQRES 27 A 490 MET VAL PHE GLN MET GLY GLU THR GLY VAL ALA GLY PHE SEQRES 28 A 490 THR ASN SER LEU ARG MET LEU GLN GLN LYS ARG TRP ASP SEQRES 29 A 490 GLU ALA ALA VAL ASN LEU ALA LYS SER ARG TRP TYR ASN SEQRES 30 A 490 GLN THR PRO ASN ARG ALA LYS ARG VAL ILE THR THR PHE SEQRES 31 A 490 ARG THR GLY THR TRP ASP ALA TYR LYS PHE CYS LEU LYS SEQRES 32 A 490 GLU HIS LYS ALA LEU LYS THR LEU GLY ILE ILE MET GLY SEQRES 33 A 490 THR PHE THR LEU CYS TRP LEU PRO PHE PHE ILE VAL ASN SEQRES 34 A 490 ILE VAL HIS VAL ILE GLN ASP ASN LEU ILE ARG LYS GLU SEQRES 35 A 490 VAL TYR ILE LEU LEU ASN TRP ILE GLY TYR VAL ASN SER SEQRES 36 A 490 GLY PHE ASN PRO LEU ILE TYR CYS ARG SER PRO ASP PHE SEQRES 37 A 490 ARG ILE ALA PHE GLN GLU LEU LEU CYS LEU ARG ARG SER SEQRES 38 A 490 SER LEU LYS HIS HIS HIS HIS HIS HIS HET CLR A1201 28 HET CLR A1202 28 HET JSZ A1203 24 HET OLC A1204 25 HETNAM CLR CHOLESTEROL HETNAM JSZ ETHYL 4-({(2S)-2-HYDROXY-3-[(1-METHYLETHYL) HETNAM 2 JSZ AMINO]PROPYL}OXY)-3-METHYL-1-BENZOFURAN-2-CARBOXYLATE HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETSYN OLC 1-OLEOYL-R-GLYCEROL FORMUL 2 CLR 2(C27 H46 O) FORMUL 4 JSZ C18 H25 N O5 FORMUL 5 OLC C21 H40 O4 FORMUL 6 HOH *8(H2 O) HELIX 1 1 TRP A 32 PHE A 61 1 30 HELIX 2 2 GLU A 62 GLN A 65 5 4 HELIX 3 3 THR A 66 VAL A 86 1 21 HELIX 4 4 VAL A 86 LYS A 97 1 12 HELIX 5 5 PHE A 101 SER A 137 1 37 HELIX 6 6 THR A 146 MET A 171 1 26 HELIX 7 7 HIS A 178 GLU A 187 1 10 HELIX 8 8 ASN A 196 PHE A 208 1 13 HELIX 9 9 PHE A 208 GLN A 229 1 22 HELIX 10 10 ASN A 1002 ASP A 1010 1 9 HELIX 11 11 SER A 1038 GLY A 1051 1 14 HELIX 12 12 THR A 1059 ASN A 1081 1 23 HELIX 13 13 LYS A 1083 LEU A 1091 1 9 HELIX 14 14 ASP A 1092 ALA A 1112 1 21 HELIX 15 15 PHE A 1114 GLN A 1123 1 10 HELIX 16 16 ARG A 1125 LYS A 1135 1 11 HELIX 17 17 SER A 1136 THR A 1142 1 7 HELIX 18 18 THR A 1142 GLY A 1156 1 15 HELIX 19 19 TRP A 1158 LYS A 263 5 5 HELIX 20 20 LEU A 266 GLN A 299 1 34 HELIX 21 21 ARG A 304 VAL A 317 1 14 HELIX 22 22 GLY A 320 TYR A 326 1 7 HELIX 23 23 SER A 329 CYS A 341 1 13 SHEET 1 A 3 ARG A1014 LYS A1019 0 SHEET 2 A 3 TYR A1025 GLY A1028 -1 O THR A1026 N TYR A1018 SHEET 3 A 3 HIS A1031 THR A1034 -1 O LEU A1033 N TYR A1025 SSBOND 1 CYS A 106 CYS A 191 1555 1555 2.05 SSBOND 2 CYS A 184 CYS A 190 1555 1555 2.05 SITE 1 AC1 2 CYS A 77 TRP A 158 SITE 1 AC2 4 CYS A 77 VAL A 81 LEU A 84 ALA A 85 SITE 1 AC3 15 ASP A 113 VAL A 114 VAL A 117 PHE A 193 SITE 2 AC3 15 TYR A 199 ALA A 200 SER A 203 SER A 207 SITE 3 AC3 15 TRP A 286 PHE A 289 PHE A 290 ASN A 293 SITE 4 AC3 15 TYR A 308 ASN A 312 TYR A 316 SITE 1 AC4 3 PHE A 49 GLN A 197 LEU A 339 CRYST1 40.580 75.900 174.180 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024643 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013175 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005741 0.00000